Preparing for Your Targeted Treatment in the Clinic

Read article

FDA Commissioner Launches A Blog

FDA Commissioner Andy von Eschenbach has joined the…
Read Article

Patient safety abstract available for download

Medelis has just published “Patient Safety in Clinical…
Read Article

In a phase I trial, how many sites is ideal?

In the last few posts we’ve been talking…
Read Article

Evaluating a trial site’s track record

This month we've been writing about selecting sites…
Read Article

Academic versus private sites

In our last post, we talked about the…
Read Article

Clinical Trial Site Selection – The Importance of a Dedicated Team

Site selection is a key decision at the…
Read Article

在美国拯救肿瘤学研究

当初创生物技术或制药公司在美国进行第一次实质性的 I/II 期、II 期或 III 期肿瘤学研究时，时间线通常会延长。 肿瘤学研究很复杂，即使是经验丰富的临床开发领导者也会因错过患者入组截止日期而受苦。随着新免疫疗法的发展，这种情况变得越来越普遍，这需要内部临床操作团队、站点以及所有 CRA…
Read Article